Cite
MLA Citation
Thomas U. Schulz et al.. “Persistent immune-related adverse events after cessation of checkpoint inhibitor therapy: Prevalence and impact on patients' health-related quality of life.” European journal of cancer, vol. 176, 2022, pp. 88–99. http://access.bl.uk/ark:/81055/vdc_100169737955.0x000020